Skip to content

Clinical trials

Phase 3 trials in The Gambia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Country / region: The Gambia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20033
20041
20071
20081
20132
20141
20161
20172
20182
20193
20202
20212
20221
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Unknown status5
Recruiting4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London School of Hygiene and Tropical Medicine18
Pfizer4
PATH2
Serum Institute of India Pvt. Ltd.2
Hospital Universitari Vall d'Hebron Research Institute1
Medicines for Malaria Venture1
University of Oxford1
University of Witwatersrand, South Africa1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Malaria11
Anemia2
Malaria, Falciparum2
Pneumonia, Pneumococcal2
Respiratory Syncytial Virus Infections2
Anemia, Hemolytic1
Anemia, Iron-Deficiency1
Bacterial Infections1
COVID-191
Glucosephosphate Dehydrogenase Deficiency1

Trials

Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.